Litcius/Paper detail

1988MO Recruitment discontinuation in TREASURE trial (thoracic radiotherapy with atezolizumab in small cell lung cancer extensive disease) due to unexpected safety data

Farastuk Bozorgmehr, Fabian Weykamp, Tobias R. Overbeck, Nicola Maguire, E.L. Buchmeier, M. Hammer-Hellmig, Thomas Gauler, Martin Wermke, Esther G.C. Troost, Matthias Ulmer, A-C. Mueller, Konrad Kokowski, Barbara Röper, Thomas Wehler, S. Hey-Koch, N.-S Consdorf, Rouven Behnisch, Petros Christopoulos, Michael Thomas, Stefan Rieken

2023Annals of Oncology14 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAtezolizumabDiscontinuationRadiation therapyLung cancerTreasureDiseaseOncologyCancerInternal medicineSurgeryPembrolizumabImmunotherapyTheologyPhilosophyLung Cancer Treatments and MutationsLung Cancer Research StudiesLung Cancer Diagnosis and Treatment
1988MO Recruitment discontinuation in TREASURE trial (thoracic radiotherapy with atezolizumab in small cell lung cancer extensive disease) due to unexpected safety data | Litcius